AD-related mitochondrial impairment involves decreasing ATP levels, oxidative phosphorylation (OXPHOS) activity, increasing ROS levels, and increasing tau phosphorylation (Ohta and Ohsawa, 2006; Swerdlow et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.